SwitzerReport

Independent. Trusted. Proven.

Investing

Investment analysis, share recommendations, and market insights.

Three promising medical device makers — Investing
Premium

Three promising medical device makers

The human healthcare industry can be a frustrating place to invest but here are three examples on the ASX that are making a good fist of establishing their respective devices in world markets.

James Dunn · September 15, 2025
Is Wesfarmers too expensive? — Investing
Premium

Is Wesfarmers too expensive?

Wesfarmers (WES) has climbed all year, trading as high as $95.17 before the release of its full year result. Now the question is: Is it too expensive and a sell? Here’s what I think.

Paul Rickard · September 8, 2025
How hot are our hot stocks? — Investing
Premium

How hot are our hot stocks?

With James Dunn in the USA this week, we’re checking on our recent “HOT” stock calls. And following reporting season, do they remain hot?

Maureen Jordan · September 8, 2025
What you need to know about Emerging Markets Bonds — Investing
Premium

What you need to know about Emerging Markets Bonds

Here are two Exchange Traded Funds (ETFs) that invest in emerging market (EM) bonds to consider. Both are quoted on the ASX and bought and sold like a share. The first is an active ETF; the second invests passively by tracking an index.

Tony Featherstone · September 4, 2025
“HOT” stock: Worley (WOR) — Investing
Premium

“HOT” stock: Worley (WOR)

In our “HOT” stock article today, Michael Gable, Managing Director of Fairmont Equities, says that in addition to the chart giving a BUY signal, there are key catalysts for its share price to improve as earnings growth improves next year.

Maureen Jordan · September 4, 2025

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.